Liu Y - Search Results

1

A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma.

Qian J, Xu Z, Zhu P, Meng C, Liu Y, Shan W, He A, Gu Y, Ran F, Zhang Y, Ling Y. Qian J, et al. Among authors: liu y. J Nat Prod. 2021 Dec 24;84(12):3161-3168. doi: 10.1021/acs.jnatprod.1c00618. Epub 2021 Nov 21. J Nat Prod. 2021. PMID: 34806369

2

Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.

Ran F, Liu Y, Wang C, Xu Z, Zhang Y, Liu Y, Zhao G, Ling Y. Ran F, et al. Among authors: liu y. Eur J Med Chem. 2022 Feb 5;229:114009. doi: 10.1016/j.ejmech.2021.114009. Epub 2021 Nov 22. Eur J Med Chem. 2022. PMID: 34839996 Review.

3

A "Double-Locked" and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy.

Luo J, Guan Z, Gao W, Wang C, Xu Z, Meng C, Liu Y, Zhang Y, Guo Q, Ling Y. Luo J, et al. Among authors: liu y. Molecules. 2022 Jan 10;27(2):425. doi: 10.3390/molecules27020425. Molecules. 2022. PMID: 35056740 Free PMC article.

4

Recent development of BTK-based dual inhibitors in the treatment of cancers.

Ran F, Liu Y, Xu Z, Meng C, Yang D, Qian J, Deng X, Zhang Y, Ling Y. Ran F, et al. Among authors: liu y. Eur J Med Chem. 2022 Apr 5;233:114232. doi: 10.1016/j.ejmech.2022.114232. Epub 2022 Feb 25. Eur J Med Chem. 2022. PMID: 35247756 Review.

5

TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity.

Xu Z, Qian J, Meng C, Liu Y, Ding Q, Wu H, Li P, Ran F, Liu GQ, Wang Y, Ling Y. Xu Z, et al. Among authors: liu y, liu gq. Theranostics. 2022 Feb 28;12(6):2535-2548. doi: 10.7150/thno.68074. eCollection 2022. Theranostics. 2022. PMID: 35401826 Free PMC article.

6

Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy.

Qian J, Xu Z, Meng C, Liu Y, Wu H, Wang Y, Yang J, Zheng H, Ran F, Liu GQ, Ling Y. Qian J, et al. Among authors: liu y, liu gq. J Med Chem. 2022 Aug 11;65(15):10393-10407. doi: 10.1021/acs.jmedchem.2c00130. Epub 2022 Jul 25. J Med Chem. 2022. PMID: 35877176

7

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.

Guo J, Yu Z, Sun D, Zou Y, Liu Y, Huang L. Guo J, et al. Among authors: liu y. Mol Cancer. 2021 Jan 6;20(1):10. doi: 10.1186/s12943-020-01297-0. Mol Cancer. 2021. PMID: 33407548 Free PMC article.

8

Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.

Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, Huang L. Yu Z, et al. Among authors: liu z, liu y. J Nanobiotechnology. 2022 Jan 4;20(1):9. doi: 10.1186/s12951-021-01205-8. J Nanobiotechnology. 2022. PMID: 34983554 Free PMC article.

9

Targeted drug delivery to melanoma.

Liu Q, Das M, Liu Y, Huang L. Liu Q, et al. Among authors: liu y. Adv Drug Deliv Rev. 2018 Mar 1;127:208-221. doi: 10.1016/j.addr.2017.09.016. Epub 2017 Sep 19. Adv Drug Deliv Rev. 2018. PMID: 28939379 Review.

10

Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma.

Hou L, Liu Q, Shen L, Liu Y, Zhang X, Chen F, Huang L. Hou L, et al. Among authors: liu y, liu q. Theranostics. 2018 Jun 13;8(14):3781-3796. doi: 10.7150/thno.24821. eCollection 2018. Theranostics. 2018. PMID: 30083259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208,150 results

Search Page

Filters